More recently, some unexpected findings have indicated that INPP4B is significantly upregulated, and plays an oncogenic role in AML, melanoma and colon cancer by activating SGK3, and that it is associated with patient prognosis [17–19, 31]. This evidence concerns the gene SGK3 and acute myeloid leukemia.